RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9784
+0.0394 (4.20%)
At close: Apr 9, 2026, 4:00 PM EDT
0.9784
0.00 (0.00%)
After-hours: Apr 9, 2026, 7:13 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $44.08 million as of April 9, 2026. Its market cap has increased by 16.92% in one year.
Market Cap
44.08M
Enterprise Value
37.27M
1-Year Change
16.92%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $44.08M, a decrease of -35.78%. That is a compound annual growth rate of -9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 44.08M | 43.16% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 45.94M |
| Lisata Therapeutics | 45.16M |
| Actuate Therapeutics | 44.82M |
| Werewolf Therapeutics | 43.66M |
| Rallybio | 43.43M |
| Telomir Pharmaceuticals | 43.32M |
| Rein Therapeutics | 42.90M |
| Atossa Therapeutics | 42.88M |